Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis

Clinical trial NCT00811902 · COMPLETED

Trial details

NCT number: NCT00811902
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-12-01
Primary completion: 2010-03-01
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.